As a memorial tribute to an extraordinary woman, Krav Maga Worldwide™ and STOP CANCER created The Marni Fund, with a shared mission dedicated to developing improved treatments, new diagnostic procedures and the ultimate goal – a cure. Created in memory of Marni Levine (1969–2006), The Marni Fund is currently supporting innovative Breast Cancer researchers at UCLA, USC and City of Hope NCI-designated Comprehensive Cancer Centers.
Today, we introduce you to one of those researchers: Dr. Sara Hurvitz.
Dr. Sara Hurvitz is a Clinical Instructor in the Division of Hematology-Oncology at UCLA who specializes in the treatment of breast cancer. She received her MD from USC and completed residency training at UCLA. She is currently leading the Breast Oncology Program in the Division of Hematology-Oncology there.
Sara is in charge of national and international breast cancer clinical trials that evaluate new promising treatments for both early stage and advanced breast cancer. She states it is clear now that breast cancer is not one disease but many different types, each with a different biological cause and each deserving of a specific therapy. Data obtained from each of these trials will provide critical information that may be used to develop new therapies.
With funds provided by the STOP CANCER Marni Levine Memorial Breast Cancer Award, Dr. Hurvitz is evaluating the safety and effectiveness of a novel medication that works by stopping the growth of new blood vessels around tumors in patients with high-risk breast cancer.